633 related articles for article (PubMed ID: 19332629)
1. Quality of life and disability in patients with treatment-failure gout.
Becker MA; Schumacher HR; Benjamin KL; Gorevic P; Greenwald M; Fessel J; Edwards L; Kawata AK; Frank L; Waltrip R; Maroli A; Huang B; ; Sundy JS
J Rheumatol; 2009 May; 36(5):1041-8. PubMed ID: 19332629
[TBL] [Abstract][Full Text] [Related]
2. Improved health-related quality of life and physical function in patients with refractory chronic gout following treatment with pegloticase: evidence from phase III randomized controlled trials.
Strand V; Khanna D; Singh JA; Forsythe A; Edwards NL
J Rheumatol; 2012 Jul; 39(7):1450-7. PubMed ID: 22660805
[TBL] [Abstract][Full Text] [Related]
3. Treatment of chronic gout. Can we determine when urate stores are depleted enough to prevent attacks of gout?
Li-Yu J; Clayburne G; Sieck M; Beutler A; Rull M; Eisner E; Schumacher HR
J Rheumatol; 2001 Mar; 28(3):577-80. PubMed ID: 11296962
[TBL] [Abstract][Full Text] [Related]
4. Foot pain, impairment, and disability in patients with acute gout flares: A prospective observational study.
Rome K; Frecklington M; McNair P; Gow P; Dalbeth N
Arthritis Care Res (Hoboken); 2012 Mar; 64(3):384-8. PubMed ID: 22006512
[TBL] [Abstract][Full Text] [Related]
5. Quality of life in patients with psoriasis: the contribution of clinical variables and psoriasis-specific stress.
Fortune DG; Main CJ; O'Sullivan TM; Griffiths CE
Br J Dermatol; 1997 Nov; 137(5):755-60. PubMed ID: 9415236
[TBL] [Abstract][Full Text] [Related]
6. Gout is associated with more comorbidities, poorer health-related quality of life and higher healthcare utilisation in US veterans.
Singh JA; Strand V
Ann Rheum Dis; 2008 Sep; 67(9):1310-6. PubMed ID: 18178692
[TBL] [Abstract][Full Text] [Related]
7. Febuxostat in the treatment of gout: 5-yr findings of the FOCUS efficacy and safety study.
Schumacher HR; Becker MA; Lloyd E; MacDonald PA; Lademacher C
Rheumatology (Oxford); 2009 Feb; 48(2):188-94. PubMed ID: 19141576
[TBL] [Abstract][Full Text] [Related]
8. Factors associated with musculoskeletal disability and chronic renal failure in clinically diagnosed primary gout.
Alvarez-Nemegyei J; Cen-Pisté JC; Medina-Escobedo M; Villanueva-Jorge S
J Rheumatol; 2005 Oct; 32(10):1923-7. PubMed ID: 16206348
[TBL] [Abstract][Full Text] [Related]
9. Health-related quality of life among haemodialysis patients--relationship with clinical indicators, morbidity and mortality.
Morsch CM; Gonçalves LF; Barros E
J Clin Nurs; 2006 Apr; 15(4):498-504. PubMed ID: 16553764
[TBL] [Abstract][Full Text] [Related]
10. Illness perceptions in patients with gout and the relationship with progression of musculoskeletal disability.
Dalbeth N; Petrie KJ; House M; Chong J; Leung W; Chegudi R; Horne A; Gamble G; McQueen FM; Taylor WJ
Arthritis Care Res (Hoboken); 2011 Nov; 63(11):1605-12. PubMed ID: 22034122
[TBL] [Abstract][Full Text] [Related]
11. Clinical efficacy and safety of successful longterm urate lowering with febuxostat or allopurinol in subjects with gout.
Becker MA; Schumacher HR; MacDonald PA; Lloyd E; Lademacher C
J Rheumatol; 2009 Jun; 36(6):1273-82. PubMed ID: 19286847
[TBL] [Abstract][Full Text] [Related]
12. Impact of noncompliance with urate-lowering drug on serum urate and gout-related healthcare costs: administrative claims analysis.
Halpern R; Mody RR; Fuldeore MJ; Patel PA; Mikuls TR
Curr Med Res Opin; 2009 Jul; 25(7):1711-9. PubMed ID: 19485724
[TBL] [Abstract][Full Text] [Related]
13. Validation of the Health Assessment Questionnaire disability index in patients with gout.
Alvarez-Hernández E; Peláez-Ballestas I; Vázquez-Mellado J; Terán-Estrada L; Bernard-Medina AG; Espinoza J; Aceves-Avila FJ; Goycochea-Robles MV; Garza M; Ventura L; Burgos-Vargas R;
Arthritis Rheum; 2008 May; 59(5):665-9. PubMed ID: 18438898
[TBL] [Abstract][Full Text] [Related]
14. Impact of oral cyclophosphamide on health-related quality of life in patients with active scleroderma lung disease: results from the scleroderma lung study.
Khanna D; Yan X; Tashkin DP; Furst DE; Elashoff R; Roth MD; Silver R; Strange C; Bolster M; Seibold JR; Riley DJ; Hsu VM; Varga J; Schraufnagel DE; Theodore A; Simms R; Wise R; Wigley F; White B; Steen V; Read C; Mayes M; Parsley E; Mubarak K; Connolly MK; Golden J; Olman M; Fessler B; Rothfield N; Metersky M; Clements PJ;
Arthritis Rheum; 2007 May; 56(5):1676-84. PubMed ID: 17469162
[TBL] [Abstract][Full Text] [Related]
15. Responsiveness of the SF-36 and the Health Assessment Questionnaire Disability Index in a systemic sclerosis clinical trial.
Khanna D; Furst DE; Clements PJ; Park GS; Hays RD; Yoon J; Korn JH; Merkel PA; Rothfield N; Wigley FM; Moreland LW; Silver R; Steen VD; Weisman M; Mayes MD; Collier DH; Medsger TA; Seibold JR; ;
J Rheumatol; 2005 May; 32(5):832-40. PubMed ID: 15868618
[TBL] [Abstract][Full Text] [Related]
16. Progress in measurement instruments for acute and chronic gout studies.
Grainger R; Taylor WJ; Dalbeth N; Perez-Ruiz F; Singh JA; Waltrip RW; Schlesinger N; Evans R; Edwards NL; Sivera F; Diaz-Torne C; MacDonald PA; McQueen FM; Schumacher HR
J Rheumatol; 2009 Oct; 36(10):2346-55. PubMed ID: 19820224
[TBL] [Abstract][Full Text] [Related]
17. Proxy-reported health-related quality of life of patients with juvenile idiopathic arthritis: the Pediatric Rheumatology International Trials Organization multinational quality of life cohort study.
Oliveira S; Ravelli A; Pistorio A; Castell E; Malattia C; Prieur AM; Saad-Magalhães C; Murray KJ; Bae SC; Joos R; Foeldvari I; Duarte-Salazar C; Wulffraat N; Lahdenne P; Dolezalova P; de Inocencio J; Kanakoudi-Tsakalidou F; Hofer M; Nikishina I; Ozdogan H; Hashkes PJ; Landgraf JM; Martini A; Ruperto N;
Arthritis Rheum; 2007 Feb; 57(1):35-43. PubMed ID: 17266064
[TBL] [Abstract][Full Text] [Related]
18. Long-term therapy for chronic gout results in clinically important improvements in the health-related quality of life: short form-36 is responsive to change in chronic gout.
Khanna PP; Perez-Ruiz F; Maranian P; Khanna D
Rheumatology (Oxford); 2011 Apr; 50(4):740-5. PubMed ID: 21147824
[TBL] [Abstract][Full Text] [Related]
19. Relationships between long-term stroke disability, handicap and health-related quality of life.
Patel MD; Tilling K; Lawrence E; Rudd AG; Wolfe CD; McKevitt C
Age Ageing; 2006 May; 35(3):273-9. PubMed ID: 16638767
[TBL] [Abstract][Full Text] [Related]
20. Serum urate levels and gout flares: analysis from managed care data.
Sarawate CA; Patel PA; Schumacher HR; Yang W; Brewer KK; Bakst AW
J Clin Rheumatol; 2006 Apr; 12(2):61-5. PubMed ID: 16601538
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
